NYLIM Fiera SMID Growth Class I holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
NYLIM Fiera SMID Growth Class I APSGX
- NAV / 1-Day Return 17.94 / +0.17 %
- Total Assets 188.1M
-
Adj. Expense Ratio
0.850%
- Expense Ratio 0.850%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Mid-Cap Growth
- Investment Style Small Growth
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.00
- Turnover 50%
USD | NAV as of Oct 07, 2026 | 1-Day Return as of Oct 07, 2026, 12:11 AM GMT+0
Morningstar’s Analysis APSGX
Will APSGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
JFrog Ltd Ordinary Shares | 4.47 | 9M | Technology |
MongoDB Inc Class A | 2.74 | 6M | Technology |
argenx SE ADR | 2.42 | 5M | Healthcare |
Insmed Inc | 2.42 | 5M | Healthcare |
Rubrik Inc Class A Shares | 2.37 | 5M | Technology |
EMCOR Group Inc | 2.12 | 4M | Industrials |
Expedia Group Inc | 2.07 | 4M | Consumer Cyclical |
Neurocrine Biosciences Inc | 2.01 | 4M | Healthcare |
IDEAYA Biosciences Inc | 1.98 | 4M | Healthcare |
Madrigal Pharmaceuticals Inc | 1.83 | 4M | Healthcare |